With over 30 years of professional experience as an economist, and an extensive University level teaching and research background, Dr. Alexandrakis has a combined managerial, research, public policy and strategy analysis background, with a special focus in the Health sector. He has served executive positions in the pharmaceutical sector and as a high-level government official in Greece and the EU.

Today, he is a Global Market Strategist at the WifOR Institute, a German independent Economic Research Organization, Adjunct Professor at the MBA International Program of the Athens University of Economics and Business for Health Sector Strategy and a Senior Research Fellow at the Management Science Laboratory of the same University. Currently, he is also Executive Member of the BoD of the Hellenic Archaeological proceeds Fund. He is also a Research Associate of the University of Piraeus Laboratory of Health Economics and Management and has also served internationally as a consultant and on the Expert Review Board of the WHO – European Office for Investment for Health and Development for Health Economy.

Before joining the Pharmaceutical Company MSD in 2012 (known as Merck & Co., Inc. in the USA and Canada) to lead the Policy, Communications and Corporate Social Responsibility (CSR) activities in Greece and Cyprus, he had served as a Senior Advisor at the Hellenic Parliament, with a key responsibility on the Economic Adjustment Program of Greece and issues related to fiscal policies and legislation. Before that, for several years, he served at high-level government positions and Committees in Greece and the EU (Special State Secretary of  the Hellenic Ministry of Tourism, Managing Director for Administration of the National Theatre of Greece, CEO of the Greek State Healthcare Organization for Seamen, Coordinator of PPP and Investment Committees, and has actively participated in several Committees that relate to Innovation and Entrepreneurship, the Pharmaceutical Industry, the Health sector, Tourism and the Insurance sector.